跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MYL-ESOMEPRAZOLE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MYL-ESOMEPRAZOLE
Authorized
STANDARD
MYL-ESOMEPRAZOLE
Mylan Pharmaceuticals ULC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
8fae92d4a4b09f62
Company
Mylan Pharmaceuticals ULC
Type
Standard
Approval Details
Approval Id
8fae92d4a4b09f62
Drug Approval Canada Name
MYL-ESOMEPRAZOLE
Product Name
MYL-ESOMEPRAZOLE
Status
Marketed
Status Date
2020-04-20
Original Market Date
2020-04-20
Din
02479427
Drug Class
Human
Dosage Form
Tablet (Delayed-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
56:28.36
Atc Original
A02BC05 ESOMEPRAZOLE
Atc Name
a 02 bc 05
Aig Number
0145162002
Company Name
Mylan Pharmaceuticals ULC
Company Address
85 Advance Road, Etobicoke, Ontario, Canada, M8Z 2S6
Active Ingredients
ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE)
40 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
8fae92d4a4b09f62
Type
Standard
Back to Health Canada Approvals